Skye Orthobiologics is a leading biotechnology company based in El Segundo, CA, specializing in the development and commercialization of innovative biologic allografts for wound care and ocular applications. With a patient registry of over 5,000 patients, Skye has demonstrated the safety and efficacy of their products, collaborating with physicians to advance drug applications and improve patient care.
Partnering with independent sales representatives, distributors, and corporate partners, Skye Biologics provides their cutting-edge line of biologic allografts to physicians across the United States and internationally. With a focus on reducing barriers to selling, Skye offers comprehensive product knowledge, on-demand guidance, and ongoing sales support, ensuring seamless access to their innovative and extensive product lineup. Additionally, Skye is approved and on contract at numerous regional, national, and government facilities, enabling immediate access to their biologics for surgeons seeking to incorporate their products into their practice.
Generated from the website